{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:16:13Z","timestamp":1791263773136,"version":"4.1.0"},"reference-count":231,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system marked by inflammatory demyelination and progressive neurodegeneration. Although current immunomodulatory therapies can reduce relapse rates, they are often associated with limited long-term efficacy and adverse effects, highlighting the need for safer and more comprehensive complementary approaches. Dietary bioactive phytochemicals\u2014notably, the polyphenols epigallocatechin-3-gallate (EGCG), curcumin, and resveratrol\u2014have demonstrated potential to modulate the immune and inflammatory pathways implicated in MS pathogenesis. In addition to their immunomodulatory roles, emerging evidence suggests that these compounds also exert neuroprotective effects independent of immune modulation, including antioxidant activity, mitochondrial stabilization, and enhancement of neurotrophic signaling. Furthermore, recent studies identify the gut microbiota as a central mediator of MS pathophysiology and of how dietary phytochemicals are metabolized and exert their effects. This review examines experimental data evaluating the therapeutic potential of selected bioactive phytochemicals in MS, focusing on their mechanisms of action\u2014including both immune-dependent and immune-independent neuroprotective effects\u2014and interactions with the gut microbiota. Current limitations in translating findings from animal models to clinical settings are also discussed, and future directions for research in this evolving area are highlighted.<\/jats:p>","DOI":"10.3390\/nu18020278","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:35:38Z","timestamp":1768487738000},"page":"278","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bioactive Phytochemicals in Experimental Models of Multiple Sclerosis: Mechanisms, Efficacy, and Translational Potential"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-7154","authenticated-orcid":false,"given":"Weimin","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine, 670 Albany Street, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin Nikbin","family":"Meydani","sequence":"additional","affiliation":[{"name":"Nutritional Immunology Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111, USA"},{"name":"Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-6374","authenticated-orcid":false,"given":"Dayong","family":"Wu","sequence":"additional","affiliation":[{"name":"Nutritional Immunology Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(14)70101-2","article-title":"Pathogenesis of multiple sclerosis: Insights from molecular and metabolic imaging","volume":"13","author":"Ciccarelli","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1212\/WNL.0000000000002469","article-title":"Multiple sclerosis prevalence in the United States commercially insured population","volume":"86","author":"Dilokthornsakul","year":"2016","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.0b013e3182872855","article-title":"Disability in multiple sclerosis: A reference for patients and clinicians","volume":"80","author":"Kister","year":"2013","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Garg, N., and Smith, T.W. (2015). An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav., 5.","DOI":"10.1002\/brb3.362"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"International Multiple Sclerosis Genetics Consortium, Beecham, A.H., Patsopoulos, N.A., Xifara, D.K., Davis, M.F., Kemppinen, A., Cotsapas, C., Shah, T.S., Spencer, C., and Booth, D. (2013). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet., 45, 1353\u20131360.","DOI":"10.1038\/ng.2770"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/eci.10.11","article-title":"Multiple sclerosis etiology: Beyond genes and environment","volume":"6","author":"Mechelli","year":"2010","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1177\/1352458512436596","article-title":"High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women","volume":"18","author":"Hedstrom","year":"2012","journal-title":"Mult. Scler."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature11868","article-title":"Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells","volume":"496","author":"Kleinewietfeld","year":"2013","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1474-4422(10)70086-7","article-title":"Vitamin D and multiple sclerosis","volume":"9","author":"Ascherio","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of Vitamin D in multiple sclerosis","volume":"132","author":"Correale","year":"2009","journal-title":"Brain"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1756285611425694","article-title":"Smoking: Effects on multiple sclerosis susceptibility and disease progression","volume":"5","author":"Wingerchuk","year":"2012","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1073858410381531","article-title":"The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis","volume":"17","author":"Pender","year":"2011","journal-title":"Neuroscientist"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11910-001-0030-x","article-title":"Infection and the etiology and pathogenesis of multiple sclerosis","volume":"1","author":"Steiner","year":"2001","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1034\/j.1600-0463.2001.090601.x","article-title":"Human herpesvirus 6 in the pathogenesis of multiple sclerosis","volume":"109","author":"Enbom","year":"2001","journal-title":"APMIS"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0065-3527(01)56037-6","article-title":"Role of viruses in etiology and pathogenesis of multiple sclerosis","volume":"56","author":"Soldan","year":"2001","journal-title":"Adv. Virus Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12017-016-8422-x","article-title":"Epigenetic Modifications and Therapy in Multiple Sclerosis","volume":"19","author":"Aslani","year":"2017","journal-title":"Neuromolecular Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1007\/s12035-016-9966-3","article-title":"DNA Methylation: A New Player in Multiple Sclerosis","volume":"54","author":"Li","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13148-015-0152-7","article-title":"Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients","volume":"7","author":"Maltby","year":"2015","journal-title":"Clin. Epigenetics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2016.04.014","article-title":"MicroRNAs associated with the pathogenesis of multiple sclerosis","volume":"295\u2013296","author":"Huang","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"13227","DOI":"10.3390\/ijms131013227","article-title":"MicroRNAs as active players in the pathogenesis of multiple sclerosis","volume":"13","author":"Fenoglio","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Naghavian, R., Ghaedi, K., Kiani-Esfahani, A., Ganjalikhani-Hakemi, M., Etemadifar, M., and Nasr-Esfahani, M.H. (2015). miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17\/Treg Differentiation and Pathogenesis of Multiple Sclerosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124555"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/brain\/awp300","article-title":"MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47","volume":"132","author":"Junker","year":"2009","journal-title":"Brain"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1089\/acm.2015.0015","article-title":"Therapeutic Yoga: Symptom Management for Multiple Sclerosis","volume":"21","author":"Rogers","year":"2015","journal-title":"J. Altern. Complement. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.msard.2016.02.006","article-title":"The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary","volume":"7","author":"Fuvesi","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"102713","DOI":"10.1016\/j.coi.2025.102713","article-title":"Diet-derived microbial metabolites as regulators of immune function","volume":"98","author":"Siracusa","year":"2025","journal-title":"Curr. Opin. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lopez-Fandino, R. (2025). Diet Components, Immune Function and IgE-Mediated Food Allergy. Nutrients, 17.","DOI":"10.20944\/preprints202510.0557.v1"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2023.10.010","article-title":"Diet and immune response: How today\u2019s plate shapes tomorrow\u2019s health","volume":"45","author":"Siracusa","year":"2024","journal-title":"Trends Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"106739","DOI":"10.1016\/j.msard.2025.106739","article-title":"Efficacy of the Mediterranean diet in the treatment of multiple sclerosis (RRMS): A systematic review and meta-analysis","volume":"104","author":"Kong","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"20250371","DOI":"10.1515\/tnsci-2025-0371","article-title":"From prevention to management: Exploring the impact of diet on multiple sclerosis","volume":"16","author":"Koukach","year":"2025","journal-title":"Trans. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/012772574X325602240910075218","article-title":"Effect of Diet and Dietary Patterns on the Progression of Multiple Sclerosis: A Review","volume":"16","author":"Khattab","year":"2025","journal-title":"Recent. Adv. Food Nutr. Agric."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Liu, R., Du, S., Zhao, L., Jain, S., Sahay, K., Rizvanov, A., Lezhnyova, V., Khaibullin, T., Martynova, E., and Khaiboullina, S. (2022). Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.996469"},{"key":"ref_35","first-page":"903","article-title":"Recent advances in understanding the pathogenesis and biological treatment of multiple sclerosis","volume":"124","author":"Buc","year":"2023","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/imm.13198","article-title":"The role of B cells in the immunopathogenesis of multiple sclerosis","volume":"160","author":"Gharibi","year":"2020","journal-title":"Immunology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kumar, G., and Axtell, R.C. (2023). Dual Role of B Cells in Multiple Sclerosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032336"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12974-020-01944-9","article-title":"Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets","volume":"17","author":"Govindarajan","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","article-title":"Animal models of Multiple Sclerosis","volume":"759","author":"Procaccini","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS: Utility for understanding disease pathophysiology and treatment","volume":"122","author":"Robinson","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2014.03.006","article-title":"Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis","volume":"160","author":"Jiang","year":"2014","journal-title":"Immunol. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","article-title":"Microglial physiology: Unique stimuli, specialized responses","volume":"27","author":"Ransohoff","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"948976","DOI":"10.1155\/2013\/948976","article-title":"The benefits and detriments of macrophages\/microglia in models of multiple sclerosis","volume":"2013","author":"Rawji","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.4049\/jimmunol.173.9.5794","article-title":"Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis","volume":"173","author":"Aktas","year":"2004","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00054725-199911000-00009","article-title":"Th1\/Th2 cells","volume":"5","author":"Romagnani","year":"1999","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0167-5699(98)01320-6","article-title":"Balancing the Th1\/Th2 concept in multiple sclerosis","volume":"19","author":"Laman","year":"1998","journal-title":"Immunol. Today"},{"key":"ref_49","first-page":"5314541","article-title":"Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications","volume":"2016","author":"Sato","year":"2016","journal-title":"Mediators Inflamm."},{"key":"ref_50","first-page":"12","article-title":"Th17 Cells in MS and Experimental Autoimmune Encephalomyelitis","volume":"16","author":"Hofstetter","year":"2009","journal-title":"Int. MS J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2011.02536.x","article-title":"Th17 cell, the new player of neuroinflammatory process in multiple sclerosis","volume":"74","author":"Mirshafiey","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Domingues, H.S., Mues, M., Lassmann, H., Wekerle, H., and Krishnamoorthy, G. (2010). Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015531"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20080159","article-title":"IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition","volume":"205","author":"Kroenke","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"475158","DOI":"10.1155\/2015\/475158","article-title":"Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis","volume":"2015","author":"Volpe","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","article-title":"Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes","volume":"183","author":"Jager","year":"2009","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-016-0610-0","article-title":"Discovery and initial characterization of Th9 cells: The early years","volume":"39","author":"Schmitt","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_57","first-page":"30","article-title":"The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis","volume":"13","author":"Fard","year":"2016","journal-title":"Innov. Clin. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"963748","DOI":"10.1155\/2013\/963748","article-title":"Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis","volume":"2013","author":"Buc","year":"2013","journal-title":"Mediators Inflamm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4049\/jimmunol.1500759","article-title":"Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis","volume":"195","author":"Dhaeze","year":"2015","journal-title":"J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2006.08.003","article-title":"CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis","volume":"180","author":"Kumar","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","article-title":"Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level","volume":"123","author":"Venken","year":"2008","journal-title":"Immunology"},{"key":"ref_64","first-page":"250","article-title":"Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(\u2212) regulatory T cells in multiple sclerosis","volume":"17","author":"Kouchaki","year":"2014","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/intimm\/dxh029","article-title":"IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells","volume":"16","author":"Zhang","year":"2004","journal-title":"Int. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis","volume":"169","author":"Kohm","year":"2002","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Claes, N., Fraussen, J., Stinissen, P., Hupperts, R., and Somers, V. (2015). B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00642"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrneurol.2012.203","article-title":"B cells and antibodies in multiple sclerosis pathogenesis and therapy","volume":"8","author":"Krumbholz","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0197-0186(95)00142-5","article-title":"Astrocytic contributions to blood-brain barrier (BBB) formation by endothelial cells: A possible use of aortic endothelial cell for in vitro BBB model","volume":"28","author":"Isobe","year":"1996","journal-title":"Neurochem. Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/307273a0","article-title":"Astrocytes present myelin basic protein to encephalitogenic T-cell lines","volume":"307","author":"Fontana","year":"1984","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/ars.2008.2215","article-title":"Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons","volume":"11","author":"Schroeder","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2015.07.013","article-title":"Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair","volume":"99","author":"Mohajeri","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Zha, Z., Liu, S., Liu, Y., Li, C., and Wang, L. (2022). Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis. Antioxidants, 11.","DOI":"10.3390\/antiox11081495"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s13311-023-01378-0","article-title":"Nanoparticles Enhance Solubility and Neuroprotective Effects of Resveratrol in Demyelinating Disease","volume":"20","author":"Shamsher","year":"2023","journal-title":"Neurotherapeutics"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1152\/jn.00510.2016","article-title":"Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice","volume":"116","author":"Wang","year":"2016","journal-title":"J. Neurophysiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Xie, C.J., Gu, A.P., Cai, J., Wu, Y., and Chen, R.C. (2018). Curcumin protects neural cells against ischemic injury in N2a cells and mouse brain with ischemic stroke. Brain Behav., 8.","DOI":"10.1002\/brb3.921"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Chuang, Y.C., Chen, S.D., Hsu, C.Y., Chen, S.F., Chen, N.C., and Jou, S.B. (2019). Resveratrol Promotes Mitochondrial Biogenesis and Protects against Seizure-Induced Neuronal Cell Damage in the Hippocampus Following Status Epilepticus by Activation of the PGC-1alpha Signaling Pathway. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040998"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1\u03b1","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s11064-010-0396-8","article-title":"Effect of oral resveratrol on the BDNF gene expression in the hippocampus of the rat brain","volume":"36","author":"Rahvar","year":"2011","journal-title":"Neurochem. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"937605","DOI":"10.1155\/2012\/937605","article-title":"Resveratrol Produces Neurotrophic Effects on Cultured Dopaminergic Neurons through Prompting Astroglial BDNF and GDNF Release","volume":"2012","author":"Zhang","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3892\/mmr.2017.6851","article-title":"Resveratrol reversed chronic restraint stress-induced impaired cognitive function in rats","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s10787-023-01399-3","article-title":"Neuroprotective effect of curcumin against experimental autoimmune encephalomyelitis-induced cognitive and physical impairments in mice: An insight into the role of the AMPK\/SIRT1 pathway","volume":"32","author":"Sadek","year":"2024","journal-title":"Inflammopharmacology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pnpbp.2009.10.016","article-title":"Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor\/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons","volume":"34","author":"Wang","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1111\/j.1755-3768.2012.02502.x","article-title":"Neuroprotective effect of epigallocatechin-3-gallate against N-methyl-D-aspartate-induced excitotoxicity in the adult rat retina","volume":"90","author":"Chen","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Park, D.J., Kang, J.B., and Koh, P.O. (2024). Epigallocatechin gallate improves neuronal damage in animal model of ischemic stroke and glutamate-exposed neurons via modulation of hippocalcin expression. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0299042"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"577067","DOI":"10.1016\/j.jneuroim.2019.577067","article-title":"Dynamic expression of autophagy-related factors in autoimmune encephalomyelitis and exploration of curcumin therapy","volume":"337","author":"Boyao","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s13105-023-00959-z","article-title":"Neurobehavioral, biochemical and histological assessment of the effects of resveratrol on cuprizone-induced demyelination in mice: Role of autophagy modulation","volume":"79","author":"Samy","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6721530","DOI":"10.1155\/2018\/6721530","article-title":"Epigallocatechin-3-Gallate (EGCG) Promotes Autophagy-Dependent Survival via Influencing the Balance of mTOR-AMPK Pathways upon Endoplasmic Reticulum Stress","volume":"2018","author":"Holczer","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Li, S., Wang, Z., Liu, G., and Chen, M. (2024). Neurodegenerative diseases and catechins: (\u2212)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1425839"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1007\/s00204-025-04063-7","article-title":"Green tea catechins: Protectors or threats to DNA? A review of their antigenotoxic and genotoxic effects","volume":"99","author":"Kacew","year":"2025","journal-title":"Arch. Toxicol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1631\/jzus.B2400040","article-title":"EGCG as a therapeutic agent: A systematic review of recent advances and challenges in nanocarrier strategies","volume":"26","author":"Wong","year":"2025","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Rovaldi, E., Di Donato, V., Paolino, G., Bruno, M., Medei, A., Nistico, S.P., Pellacani, G., Kiss, N., Azzella, G., and Banvolgyi, A. (2025). Epigallocatechin-Gallate (EGCG): An Essential Molecule for Human Health and Well-Being. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26189253"},{"key":"ref_93","first-page":"1","article-title":"Unlocking the biomedical potential of epigallocatechin-3-gallate: A review on bioactive properties, stability limitations, and nano-delivery innovations","volume":"39","author":"Khan","year":"2025","journal-title":"Nat. Prod. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/07315724.2006.10719518","article-title":"Beneficial effects of green tea\u2014A review","volume":"25","author":"Cabrera","year":"2006","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2183\/pjab.88.88","article-title":"Health-promoting effects of green tea","volume":"88","author":"Suzuki","year":"2012","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1039\/c3fo60076a","article-title":"Immunomodulating effects of epigallocatechin-3-gallate from green tea: Mechanisms and applications","volume":"4","author":"Pae","year":"2013","journal-title":"Food Funct."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/jim-2016-000158","article-title":"Green tea EGCG, T-cell function, and T-cell-mediated autoimmune encephalomyelitis","volume":"64","author":"Wu","year":"2016","journal-title":"J. Investig. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mam.2011.10.001","article-title":"Green tea EGCG, T cells, and T cell-mediated autoimmune diseases","volume":"33","author":"Wu","year":"2012","journal-title":"Mol. Aspects Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"104421","DOI":"10.1016\/j.cellimm.2021.104421","article-title":"Epigallocatechin-3 gallate regulates macrophage subtypes and immunometabolism to ameliorate experimental autoimmune encephalomyelitis","volume":"368","author":"Cai","year":"2021","journal-title":"Cell. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Schuldesz, A.C., Tudor, R., Nandarge, P.S., Elagez, A., Cornea, A., Ion, R., Bratosin, F., Prodan, M., and Simu, M. (2024). The Effects of Epigallocatechin-3-Gallate Nutritional Supplementation in the Management of Multiple Sclerosis: A Systematic Review of Clinical Trials. Nutrients, 16.","DOI":"10.3390\/nu16162723"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"100537","DOI":"10.1016\/j.crfs.2023.100537","article-title":"Green tea EGCG inhibits naive CD4(+) T cell division and progression in mice: An integration of network pharmacology, molecular docking and experimental validation","volume":"7","author":"Niu","year":"2023","journal-title":"Curr. Res. Food Sci."},{"key":"ref_102","first-page":"3312","article-title":"Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals","volume":"9","author":"Chow","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/147323000303100205","article-title":"A single ascending dose study of epigallocatechin gallate in healthy volunteers","volume":"31","author":"Ullmann","year":"2003","journal-title":"J. Int. Med. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jnutbio.2005.03.003","article-title":"Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals","volume":"16","author":"Henning","year":"2005","journal-title":"J. Nutr. Biochem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1093\/jn\/133.12.4172","article-title":"Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice","volume":"133","author":"Lambert","year":"2003","journal-title":"J. Nutr."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.foodchem.2011.02.038","article-title":"Assessment of plasma concentrations of (\u2212)-epigallocatechin gallate in mice following administration of a dose reflecting consumption of a standard green tea beverage","volume":"128","author":"Dube","year":"2011","journal-title":"Food Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajpath.2011.09.007","article-title":"Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets","volume":"180","author":"Wang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2741\/4104","article-title":"Novel immunoregulatory properties of EGCG on reducing inflammation in EAE","volume":"18","author":"Sun","year":"2013","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Herges, K., Millward, J.M., Hentschel, N., Infante-Duarte, C., Aktas, O., and Zipp, F. (2011). Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025456"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Janssen, A., Fiebiger, S., Bros, H., Hertwig, L., Romero-Suarez, S., Hamann, I., Chanvillard, C., Bellmann-Strobl, J., Paul, F., and Millward, J.M. (2015). Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130251"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3945\/ajcn.113.075309","article-title":"Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: A randomized clinical trial","volume":"101","author":"Mahler","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2015.08.006","article-title":"Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies","volume":"358","author":"Lovera","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Di Penta, A., Moreno, B., Reix, S., Fernandez-Diez, B., Villanueva, M., Errea, O., Escala, N., Vandenbroeck, K., Comella, J.X., and Villoslada, P. (2013). Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054722"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/0192-0561(92)90011-9","article-title":"Mitogenic activity of (\u2212)epigallocatechin gallate on B-cells and investigation of its structure-function relationship","volume":"14","author":"Hu","year":"1992","journal-title":"Int. J. Immunopharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3727\/000000007783464515","article-title":"Tea polyphenol inhibits allostimulation in mixed lymphocyte culture","volume":"16","author":"Kim","year":"2007","journal-title":"Cell Transplant."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/107555302760253667","article-title":"In vitro immunomodulatory effects of ten commonly used herbs on murine lymphocytes","volume":"8","author":"Wilasrusmee","year":"2002","journal-title":"J. Altern. Complement. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.freeradbiomed.2009.06.001","article-title":"Green tea EGCG suppresses T cell proliferation through impairment of IL-2\/IL-2 receptor signaling","volume":"47","author":"Wu","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3945\/jn.110.124743","article-title":"Epigallocatechin-3-gallate directly suppresses T cell proliferation through impaired IL-2 utilization and cell cycle progression","volume":"140","author":"Pae","year":"2010","journal-title":"J. Nutr."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"28370","DOI":"10.1074\/jbc.M802200200","article-title":"(\u2212)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase","volume":"283","author":"Shim","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3945\/jn.111.154419","article-title":"Epigallocatechin-3-gallate inhibits expression of receptors for T cell regulatory cytokines and their downstream signaling in mouse CD4+ T cells","volume":"142","author":"Wang","year":"2012","journal-title":"J. Nutr."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/2319-4170.155590","article-title":"T cell mediated pathogenesis in EAE: Molecular mechanisms","volume":"38","author":"Kurschus","year":"2015","journal-title":"Biomed. J."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00109-012-0964-2","article-title":"Green tea epigallocatechin-3-gallate modulates differentiation of naive CD4(+) T cells into specific lineage effector cells","volume":"91","author":"Wang","year":"2013","journal-title":"J. Mol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-5728(93)90023-R","article-title":"Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: An indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier","volume":"47","author":"Rieckmann","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-5728(93)90070-F","article-title":"Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage","volume":"43","author":"Sharief","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4049\/jimmunol.178.2.851","article-title":"Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis","volume":"178","author":"Bullard","year":"2007","journal-title":"J. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.21748","article-title":"Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis","volume":"66","author":"Kebir","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.1716","article-title":"C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE","volume":"10","author":"Reboldi","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"100275","DOI":"10.5493\/wjem.v15.i1.100275","article-title":"Impact of curcumin on gut microbiome","volume":"15","author":"Balaji","year":"2025","journal-title":"World J. Exp. Med."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Zhu, J., and He, L. (2024). The Modulatory Effects of Curcumin on the Gut Microbiota: A Potential Strategy for Disease Treatment and Health Promotion. Microorganisms, 12.","DOI":"10.3390\/microorganisms12040642"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Jabczyk, M., Nowak, J., Hudzik, B., and Zubelewicz-Szkodzinska, B. (2021). Curcumin and Its Potential Impact on Microbiota. Nutrients, 13.","DOI":"10.3390\/nu13062004"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Di Meo, F., Margarucci, S., Galderisi, U., Crispi, S., and Peluso, G. (2019). Curcumin, Gut Microbiota, and Neuroprotection. Nutrients, 11.","DOI":"10.3390\/nu11102426"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Pluta, R., Januszewski, S., and Ulamek-Koziol, M. (2020). Mutual Two-Way Interactions of Curcumin and Gut Microbiota. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031055"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Khadka, S., Omura, S., Sato, F., Nishio, K., Kakeya, H., and Tsunoda, I. (2021). Curcumin beta-D-Glucuronide Modulates an Autoimmune Model of Multiple Sclerosis with Altered Gut Microbiota in the Ileum and Feces. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.772962"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.4049\/jimmunol.168.12.6506","article-title":"Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes","volume":"168","author":"Natarajan","year":"2002","journal-title":"J. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jnutbio.2011.10.002","article-title":"Differential regulation of CD4(+) T helper cell responses by curcumin in experimental autoimmune encephalomyelitis","volume":"23","author":"Kanakasabai","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10875-008-9202-7","article-title":"15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte","volume":"28","author":"Chearwae","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.intimp.2009.01.025","article-title":"Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production","volume":"9","author":"Xie","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"44482","DOI":"10.1038\/srep44482","article-title":"Nutritional control of IL-23\/Th17-mediated autoimmune disease through HO-1\/STAT3 activation","volume":"7","author":"Bruck","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/phrs.1998.0404","article-title":"Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages","volume":"39","author":"Abe","year":"1999","journal-title":"Pharmacol. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1155\/2007\/10767","article-title":"Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) blocks the chemotaxis of neutrophils by inhibiting signal transduction through IL-8 receptors","volume":"2007","author":"Takahashi","year":"2007","journal-title":"Mediators Inflamm."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ptr.3694","article-title":"Curcumin attenuates TNF-alpha-induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and proinflammatory cytokines in human endometriotic stromal cells","volume":"26","author":"Kim","year":"2012","journal-title":"Phytother. Res."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Arshad, L., Jantan, I., Bukhari, S.N., and Haque, M.A. (2017). Immunosuppressive Effects of Natural alpha,beta-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00022"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bcp.2004.03.015","article-title":"Immunomodulatory activity of curcumin: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro","volume":"68","author":"Gao","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s11095-008-9579-2","article-title":"Different curcuminoids inhibit T-lymphocyte proliferation independently of their radical scavenging activities","volume":"25","author":"Deters","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jss.2004.04.004","article-title":"Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling","volume":"121","author":"Ranjan","year":"2004","journal-title":"J. Surg. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/jsre.1998.5374","article-title":"Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation","volume":"77","author":"Ranjan","year":"1998","journal-title":"J. Surg. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1582-4934.2007.00089.x","article-title":"Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells","volume":"11","author":"Fahey","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5114\/ceji.2015.56970","article-title":"Treatment of low doses curcumin could modulate Th17\/Treg balance specifically on CD4+ T cell cultures of systemic lupus erythematosus patients","volume":"40","author":"Handono","year":"2015","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2016.05.020","article-title":"Curcumin ameliorates experimental autoimmune myasthenia gravis by diverse immune cells","volume":"626","author":"Wang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2008.07.051","article-title":"Curcumin prevents human dendritic cell response to immune stimulants","volume":"374","author":"Shirley","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2249.2010.04232.x","article-title":"Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo","volume":"162","author":"Rogers","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.4161\/cc.7.8.5740","article-title":"Resveratrol: A multitargeted agent for age-associated chronic diseases","volume":"7","author":"Harikumar","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbadis.2014.12.024","article-title":"Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes","volume":"1852","author":"Poulsen","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1080\/10408398.2022.2159921","article-title":"Resveratrol in disease prevention and health promotion: A role of the gut microbiome","volume":"64","author":"Chen","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Inchingolo, A.D., Malcangi, G., Inchingolo, A.M., Piras, F., Settanni, V., Garofoli, G., Palmieri, G., Ceci, S., Patano, A., and De Leonardis, N. (2022). Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the Literature. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23074027"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1167\/iovs.07-0131","article-title":"SIRT1 activation confers neuroprotection in experimental optic neuritis","volume":"48","author":"Shindler","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1124\/mol.107.038984","article-title":"Resveratrol (trans-3,5,4\u2032-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor","volume":"72","author":"Singh","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","article-title":"Oral resveratrol reduces neuronal damage in a model of multiple sclerosis","volume":"30","author":"Shindler","year":"2010","journal-title":"J. Neuroophthalmol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Fonseca-Kelly, Z., Nassrallah, M., Uribe, J., Khan, R.S., Dine, K., Dutt, M., and Shindler, K.S. (2012). Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front. Neurol., 3.","DOI":"10.3389\/fneur.2012.00084"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.intimp.2008.10.015","article-title":"Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression","volume":"9","author":"Imler","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijdevneu.2016.01.005","article-title":"Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis","volume":"49","author":"Wang","year":"2016","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1007\/s12035-016-9891-5","article-title":"Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study","volume":"54","author":"Ghaiad","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.ajpath.2013.07.006","article-title":"Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis","volume":"183","author":"Sato","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ijdevneu.2013.06.010","article-title":"Resveratrol improves postnatal hippocampal neurogenesis and brain derived neurotrophic factor in prenatally stressed rats","volume":"31","author":"Madhyastha","year":"2013","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Torres-Perez, M., Tellez-Ballesteros, R.I., Ortiz-Lopez, L., Ichwan, M., Vega-Rivera, N.M., Castro-Garcia, M., Gomez-Sanchez, A., Kempermann, G., and Ramirez-Rodriguez, G.B. (2015). Resveratrol Enhances Neuroplastic Changes, Including Hippocampal Neurogenesis, and Memory in Balb\/C Mice at Six Months of Age. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145687"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2015.08.018","article-title":"Sustained neurological recovery induced by resveratrol is associated with angioneurogenesis rather than neuroprotection after focal cerebral ischemia","volume":"83","author":"Hermann","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1021\/jf403286w","article-title":"Resveratrol attenuates high-fat diet-induced disruption of the blood-brain barrier and protects brain neurons from apoptotic insults","volume":"62","author":"Chang","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1753-4887.2008.00109.x","article-title":"Resveratrol and novel potent activators of SIRT1: Effects on aging and age-related diseases","volume":"66","author":"Knutson","year":"2008","journal-title":"Nutr. Rev."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm.2558","article-title":"Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets","volume":"18","author":"Jiang","year":"2011","journal-title":"Nat. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3892\/ijmm.2016.2806","article-title":"SIRT1 exerts neuroprotective effects by attenuating cerebral ischemia\/reperfusion-induced injury via targeting p53\/microRNA-22","volume":"39","author":"Lu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/icb.2011.102","article-title":"Sirtuin 1 in immune regulation and autoimmunity","volume":"90","author":"Kong","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.4049\/jimmunol.1202584","article-title":"Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets","volume":"190","author":"Nimmagadda","year":"2013","journal-title":"J. Immunol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","article-title":"Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course","volume":"185","author":"Zhou","year":"2022","journal-title":"Cell"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"106151","DOI":"10.1016\/j.msard.2024.106151","article-title":"The multiple sclerosis gut microbiome and disease activity: A systematic review","volume":"92","author":"Jette","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Dunalska, A., Saramak, K., and Szejko, N. (2023). The Role of Gut Microbiome in the Pathogenesis of Multiple Sclerosis and Related Disorders. Cells, 12.","DOI":"10.3390\/cells12131760"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"101427","DOI":"10.1016\/j.msard.2019.101427","article-title":"The multiple sclerosis gut microbiota: A systematic review","volume":"37","author":"Mirza","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Leyrolle, Q., Prado-Perez, L., and Laye, S. (2023). The gut-derived metabolites as mediators of the effect of healthy nutrition on the brain. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1155533"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"578696","DOI":"10.1016\/j.jneuroim.2025.578696","article-title":"Gut dysbiosis influences the pathophysiology of multiple sclerosis: A case-control study from North India","volume":"407","author":"Kaur","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"E9318","DOI":"10.1073\/pnas.1615715114","article-title":"Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood","volume":"114","author":"Yadav","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.3748\/wjg.v24.i37.4217","article-title":"Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome","volume":"24","author":"Metz","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Warren, A., Nyavor, Y., Zarabian, N., Mahoney, A., and Frame, L.A. (2024). The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: A narrative review of the emerging literature. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1365673"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Pellizoni, F.P., Leite, A.Z., Rodrigues, N.C., Ubaiz, M.J., Gonzaga, M.I., Takaoka, N.N.C., Mariano, V.S., Omori, W.P., Pinheiro, D.G., and Matheucci Junior, E. (2021). Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18094621"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"154979","DOI":"10.1016\/j.phymed.2023.154979","article-title":"Interactions between gut microbiota and polyphenols: A mechanistic and metabolomic review","volume":"119","author":"Cheng","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11101-016-9459-z","article-title":"The Chemistry of Gut Microbial Metabolism of Polyphenols","volume":"15","author":"Stevens","year":"2016","journal-title":"Phytochem. Rev."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/10408398.2018.1546669","article-title":"Bioactivity of dietary polyphenols: The role of metabolites","volume":"60","author":"Luca","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Yu, W., Zhang, L., Wang, M., and Chang, W. (2022). The Interaction of Polyphenols and the Gut Microbiota in Neurodegenerative Diseases. Nutrients, 14.","DOI":"10.3390\/nu14245373"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Stohs, S.J., Chen, O., Ray, S.D., Ji, J., Bucci, L.R., and Preuss, H.G. (2020). Highly Bioavailable Forms of Curcumin and Promising Avenues for Curcumin-Based Research and Application: A Review. Molecules, 25.","DOI":"10.3390\/molecules25061397"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Makarewicz, M., Drozdz, I., Tarko, T., and Duda-Chodak, A. (2021). The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota. Antioxidants, 10.","DOI":"10.3390\/antiox10020188"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Rodriguez-Daza, M.C., Pulido-Mateos, E.C., Lupien-Meilleur, J., Guyonnet, D., Desjardins, Y., and Roy, D. (2021). Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.689456"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3233\/JAD-171151","article-title":"The Role of the Gut Microbiota in the Metabolism of Polyphenols as Characterized by Gnotobiotic Mice","volume":"63","author":"Pasinetti","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"103338","DOI":"10.1016\/j.copbio.2025.103338","article-title":"Unveiling the prebiotic potential of polyphenols in gut health and metabolism","volume":"95","author":"Petersen","year":"2025","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Plamada, D., and Vodnar, D.C. (2021). Polyphenols-Gut Microbiota Interrelationship: A Transition to a New Generation of Prebiotics. Nutrients, 14.","DOI":"10.3390\/nu14010137"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1021\/acs.jafc.0c03587","article-title":"Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro","volume":"68","author":"Liu","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"La Rosa, G., Lonardo, M.S., Cacciapuoti, N., Muscariello, E., Guida, B., Faraonio, R., Santillo, M., and Damiano, S. (2023). Dietary Polyphenols, Microbiome, and Multiple Sclerosis: From Molecular Anti-Inflammatory and Neuroprotective Mechanisms to Clinical Evidence. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087247"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1080\/10408398.2023.2180478","article-title":"Gut microbiota-mediated metabolism of green tea catechins and the biological consequences: An updated review","volume":"64","author":"Liu","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1208\/s12248-015-9811-z","article-title":"Therapeutic Applications of Curcumin Nanoformulations","volume":"17","author":"Yallapu","year":"2015","journal-title":"AAPS J."},{"key":"ref_197","first-page":"100047","article-title":"Resveratrol: A comprehensive review of its multifaceted health benefits, mechanisms of action, and potential therapeutic applications in chronic disease","volume":"3","author":"Vikal","year":"2024","journal-title":"Pharmacol. Res.-Nat. Prod."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Med."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/bdd.2049","article-title":"Selective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in rat","volume":"38","author":"Zeng","year":"2017","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_200","first-page":"682","article-title":"Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats","volume":"131","author":"Suresh","year":"2010","journal-title":"Indian J. Med. Res."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/jn\/134.8.1948","article-title":"Piperine enhances the bioavailability of the tea polyphenol (\u2212)-epigallocatechin-3-gallate in mice","volume":"134","author":"Lambert","year":"2004","journal-title":"J. Nutr."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/mnfr.201100117","article-title":"Enhancing the bioavailability of resveratrol by combining it with piperine","volume":"55","author":"Johnson","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1158\/1078-0432.CCR-06-1839","article-title":"Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin","volume":"13","author":"Tamvakopoulos","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/mnfr.200700148","article-title":"Curcumin in cancer management: Recent results of analogue design and clinical studies and desirable future research","volume":"52","author":"Steward","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-0-387-46401-5_2","article-title":"Highly active anticancer curcumin analogues","volume":"595","author":"Mosley","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/jcb.25533","article-title":"Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines","volume":"117","author":"Ahmed","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2016.07.046","article-title":"Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence","volume":"789","author":"Kosuru","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jnutbio.2013.10.002","article-title":"Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals","volume":"25","author":"Wang","year":"2014","journal-title":"J. Nutr. Biochem."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00204-015-1521-x","article-title":"Hepatotoxicity of green tea: An update","volume":"89","author":"Mazzanti","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00228-008-0610-7","article-title":"Hepatotoxicity from green tea: A review of the literature and two unpublished cases","volume":"65","author":"Mazzanti","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2165\/11317010-000000000-00000","article-title":"Interactions between herbal medicines and prescribed drugs: An updated systematic review","volume":"69","author":"Izzo","year":"2009","journal-title":"Drugs"},{"key":"ref_212","first-page":"471","article-title":"Interactions of gut microbiota with dietary polyphenols and consequences to human health","volume":"19","author":"Selma","year":"2016","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"105762","DOI":"10.1016\/j.msard.2024.105762","article-title":"A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement","volume":"89","author":"Walker","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1177\/0963689719873890","article-title":"The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials","volume":"28","author":"Schepici","year":"2019","journal-title":"Cell Transplant."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jnutbio.2014.11.006","article-title":"Anthocyanins suppress the secretion of proinflammatory mediators and oxidative stress, and restore ion pump activities in demyelination","volume":"26","author":"Carvalho","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2174\/1389450118666161108124414","article-title":"Recent Updates in Imperative Natural Compounds for Healthy Brain and Nerve Function: A Systematic Review of Implications for Multiple Sclerosis","volume":"18","author":"Sanadgol","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"117906","DOI":"10.1016\/j.biopha.2025.117906","article-title":"Prevention of motor relapses and associated trigeminal pain in experimental autoimmune encephalomyelitis by reducing neuroinflammation with a purple corn extract enriched in anthocyanins","volume":"184","author":"Magni","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11481-015-9617-x","article-title":"Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions","volume":"11","author":"Ginwala","year":"2016","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2015.08.017","article-title":"Chrysin suppresses human CD14(+) monocyte-derived dendritic cells and ameliorates experimental autoimmune encephalomyelitis","volume":"288","author":"Zhang","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"577007","DOI":"10.1016\/j.jneuroim.2019.577007","article-title":"Chrysin suppress immune responses and protects from experimental autoimmune encephalomyelitis in mice","volume":"335","author":"Souza","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.intimp.2011.12.025","article-title":"Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment","volume":"12","author":"Castro","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.intimp.2008.05.002","article-title":"Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis","volume":"8","author":"Rodrigues","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00011-018-1146-7","article-title":"Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis","volume":"67","author":"Dias","year":"2018","journal-title":"Inflamm. Res."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jneuroim.2016.11.009","article-title":"Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis","volume":"302","author":"Haghmorad","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11064-015-1571-8","article-title":"Hesperidin, a Citrus Flavonoid, Has the Ameliorative Effects Against Experimental Autoimmune Encephalomyelitis (EAE) in a C57BL\/J6 Mouse Model","volume":"40","author":"Ciftci","year":"2015","journal-title":"Neurochem. Res."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1039\/C6FO00825A","article-title":"Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway","volume":"7","author":"Zhang","year":"2016","journal-title":"Food Funct."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Li, J., Xiang, H., Huang, C., and Lu, J. (2021). Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.797298"},{"key":"ref_228","first-page":"252","article-title":"Dietary Supplementation with Naringenin Attenuates Experimental Autoimmune Encephalomyelitis in Mice","volume":"29","author":"Wang","year":"2015","journal-title":"FASEB J."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"100146","DOI":"10.1016\/j.crphys.2025.100146","article-title":"Protective effect of the Quercetin on experimental cuprizone-induced multiple sclerosis in male C57BL\/6 mice","volume":"8","author":"Ghasemi","year":"2025","journal-title":"Curr. Res. Physiol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"116980","DOI":"10.1016\/j.taap.2024.116980","article-title":"Quercetin regulates dendritic cell activation by targeting STAT4 in the treatment of experimental autoimmune encephalomyelitis","volume":"488","author":"Zhou","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Javanbakht, P., Yazdi, F.R., Taghizadeh, F., Khadivi, F., Hamidabadi, H.G., Kashani, I.R., Zarini, D., and Mojaverrostami, S. (2023). Quercetin as a possible complementary therapy in multiple sclerosis: Anti-oxidative, anti-inflammatory and remyelination potential properties. Heliyon, 9.","DOI":"10.1016\/j.heliyon.2023.e21741"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/2\/278\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:50:13Z","timestamp":1768488613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/2\/278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":231,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["nu18020278"],"URL":"https:\/\/doi.org\/10.3390\/nu18020278","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}